Alterity Therapeutics Limited Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATH

Hisse Senetlerindeki Sıralama #26247
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Hisse Fiyatı
$0.18265392
Piyasa Değeri
$39.91M
Değişim (1 gün)
1.96%
Değişim (1 yıl)
-47.81%
Ülke
AU
Ticaret Alterity Therapeutics Limited (ATH)

Kategori

Healthcare
Alterity Therapeutics Limited (ATH) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.33 - 2026-10-01

Gün sonu en düşük fiyat: $13.50 - 2012-09-01
Alterity Therapeutics Limited için hisse fiyatı geçmişi: 2012 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -12.13%
2025 75.00%
2024 -18.18%
2023 -37.61%
2022 -59.70%
2021 -39.12%
2020 63.99%
2019 -39.67%
2018 -32.87%
2017 8.20%
2016 -48.69%
2015 -55.45%
2014 -69.99%
2013 162.07%
2012 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$527.18 23.62%
US
$251.29 835.90%
US
$137.07 -4.31%
AU
$890.85 9.42%
NL
$752.87 7.01%
CH